Paul Blanchfield
Net worth: 7 M $ as of 2026-08-30
Net worth: 7 M $ as of 2026-08-30
Paul Blanchfield is Chief Executive Officer & Director at Alpha-9 Oncology, Inc. since 2025.
Former roles include President at Lantheus Holdings, Inc. from 2023 to 2025, General Manager-Nordic Baltics at Shire Plc, and Head-US Immunology Business Unit at Takeda Pharmaceutical Co., Ltd. Education includes undergraduate studies at Duke University and graduate and MBA degrees from Stanford University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-16 | 69,426 ( 0.11% ) | 7 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Chief Executive Officer | 2025-11-09 |
| Companies | Position | End |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | President | 2025-11-06 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Lantheus Holdings, Inc.
Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions